{"transactions":[{"id":1429387,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-19T16:26:41.000Z","date":"2024-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":56333,"price":0.6,"value":33799.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards."},{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 274,584 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 245,568 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates."}],"balance_after":943736,"source":{"system":"sec-edgar","filing":"0001235802-24-000066","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580224000066/primary_doc.xml","form_type":"4"}},{"id":1546713,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-04-05T16:37:33.000Z","date":"2024-04-03","kind":"grant","planned":false,"acquired":true,"shares":184209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares will vest and be issued with respect to 46,052 shares on each of April 3, 2025, April 3, 2026, and April 3, 2027 and with respect to 46,053 shares on April 3, 2028 pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 304,708 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 412,411 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting dates."}],"balance_after":1000069,"source":{"system":"sec-edgar","filing":"0001235802-24-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580224000030/primary_doc.xml","form_type":"4"}},{"id":1736808,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-11-17T16:42:41.000Z","date":"2023-11-17","kind":"purchase","planned":false,"acquired":true,"shares":41670,"price":1.196,"value":49837.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.228, inclusive.  The reporting person undertakes to provide to Xtant Medical Holdings, Inc., any security holder of Xtant Medical Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 120,499 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 412,411 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates."}],"balance_after":815860,"source":{"system":"sec-edgar","filing":"0001235802-23-000112","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580223000112/primary_doc.xml","form_type":"4"}},{"id":1803630,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-08-17T16:46:52.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":140583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests with respect to 35,146 shares on August 15, 2024 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date."}],"balance_after":140583,"derivative":{"exercise_price":1.2,"expiration_date":"2033-08-15","underlying":"Common Stock","underlying_shares":140583},"source":{"system":"sec-edgar","filing":"0001235802-23-000095","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580223000095/primary_doc.xml","form_type":"4"}},{"id":1803629,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-08-17T16:46:52.000Z","date":"2023-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":49880,"price":1.18,"value":58858.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 120,499 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 412,411 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates."}],"balance_after":774190,"source":{"system":"sec-edgar","filing":"0001235802-23-000095","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580223000095/primary_doc.xml","form_type":"4"}},{"id":1803628,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-08-17T16:46:52.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":120499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares will vest and be issued with respect to 30,125 shares on each of August 15, 2024, August 15, 2025 and August 15, 2026 and with respect to 30,124 shares on August 15, 2027 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 120,499 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 412,411 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates."}],"balance_after":824070,"source":{"system":"sec-edgar","filing":"0001235802-23-000095","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580223000095/primary_doc.xml","form_type":"4"}},{"id":2181772,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock, $0.000001 par value","published_at":"2022-08-17T17:28:24.000Z","date":"2022-08-17","kind":"sale","acquired":false,"shares":4300,"price":0.4766,"value":2049.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $0.47 to $0.4953, inclusive.  The reporting person undertakes to provide to Xtant Medical Holdings, Inc., any security holder of Xtant Medical Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 588,046 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan."}],"balance_after":703571,"source":{"system":"sec-edgar","filing":"0001235802-22-000101","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580222000101/primary_doc.xml","form_type":"4"}},{"id":2181771,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock, $0.000001 par value","published_at":"2022-08-17T17:28:24.000Z","date":"2022-08-16","kind":"sale","acquired":false,"shares":18700,"price":0.4905,"value":9172.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $0.47161 to $0.52, inclusive.  The reporting person undertakes to provide to Xtant Medical Holdings, Inc., any security holder of Xtant Medical Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 588,046 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan."}],"balance_after":707871,"source":{"system":"sec-edgar","filing":"0001235802-22-000101","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580222000101/primary_doc.xml","form_type":"4"}},{"id":2181770,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock, $0.000001 par value","published_at":"2022-08-17T17:28:24.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":410079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares will vest and be issued with respect to 102,520 shares on each of August 15, 2023, August 15, 2024 and August 15, 2025 and with respect to 102,519 shares on August 15, 2026 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 588,046 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan."}],"balance_after":726571,"source":{"system":"sec-edgar","filing":"0001235802-22-000101","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580222000101/primary_doc.xml","form_type":"4"}},{"id":2600262,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-17T17:32:15.000Z","date":"2021-08-15","kind":"grant","acquired":true,"shares":199519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests with respect to 49,879 shares on August 15, 2021 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc."}],"balance_after":199519,"derivative":{"exercise_price":1.27,"expiration_date":"2031-08-15","underlying":"Common Stock","underlying_shares":199519},"source":{"system":"sec-edgar","filing":"0001235802-21-000108","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580221000108/primary_doc.xml","form_type":"4"}},{"id":2600261,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock, $0.000001 par value","published_at":"2021-08-17T17:32:15.000Z","date":"2021-08-15","kind":"tax_withholding","acquired":false,"shares":7169,"price":1.2,"value":8602.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 251,081 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan."}],"balance_after":316492,"source":{"system":"sec-edgar","filing":"0001235802-21-000108","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580221000108/primary_doc.xml","form_type":"4"}},{"id":2600260,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock, $0.000001 par value","published_at":"2021-08-17T17:32:15.000Z","date":"2021-08-15","kind":"grant","acquired":true,"shares":162109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares will vest and be issued with respect to 40,527 shares on each of August 15, 2022, August 15, 2023 and August 15, 2024 and with respect to 40,528 shares on August 15, 2025 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 251,081 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan."}],"balance_after":323661,"source":{"system":"sec-edgar","filing":"0001235802-21-000108","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580221000108/primary_doc.xml","form_type":"4"}},{"id":2634933,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock, $0.000001 par value","published_at":"2021-07-13T17:03:14.000Z","date":"2021-07-09","kind":"tax_withholding","acquired":false,"shares":8800,"price":1.74,"value":15312.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 121,560 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan."}],"balance_after":161552,"source":{"system":"sec-edgar","filing":"0001235802-21-000075","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580221000075/primary_doc.xml","form_type":"4"}},{"id":3054443,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-18T20:15:50.000Z","date":"2020-08-15","kind":"grant","acquired":true,"shares":119942,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests with respect to 29,986 shares on August 15, 2021 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments., subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc."}],"balance_after":119942,"derivative":{"exercise_price":1.13,"expiration_date":"2030-08-15","underlying":"Common Stock","underlying_shares":119942},"source":{"system":"sec-edgar","filing":"0001235802-20-000097","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580220000097/primary_doc.xml","form_type":"4"}},{"id":3054442,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock, $0.000001 par value","published_at":"2020-08-18T20:15:50.000Z","date":"2020-08-15","kind":"grant","acquired":true,"shares":95183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares will vest and be issued with respect to 23,796 shares on each of August 15, 2021, August 15, 2022 and August 15, 2023 and with respect to 23,795 shares on August 15, 2024 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 161,560 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan."}],"balance_after":170352,"source":{"system":"sec-edgar","filing":"0001235802-20-000097","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580220000097/primary_doc.xml","form_type":"4"}},{"id":3436294,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-08-16T16:20:55.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":40527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests with respect to 10,131 shares on August 15, 2020 and with respect to 10,132 shares on each of August 15, 2021, August 15, 2022 and August 15, 2023, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc."}],"balance_after":40527,"derivative":{"exercise_price":2.76,"expiration_date":"2029-08-15","underlying":"Common Stock","underlying_shares":40527},"source":{"system":"sec-edgar","filing":"0001235802-19-000104","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580219000104/primary_doc.xml","form_type":"4"}},{"id":3436293,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock, $0.000001 par value","published_at":"2019-08-16T16:20:55.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":35169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares will vest and be issued with respect to 8,792 shares on each of August 15, 2020, August 15, 2021 and August 15, 2022 and with respect to 8,793 shares on August 15, 2023 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan."}],"balance_after":75169,"source":{"system":"sec-edgar","filing":"0001235802-19-000104","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580219000104/primary_doc.xml","form_type":"4"}},{"id":3841967,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-08-16T16:54:49.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":30770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests with respect to 7,692 shares on each of August 15, 2019 and August 15, 2020 and with respect to 7,693 shares on each of August 15, 2021 and August 15, 2022, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc."}],"balance_after":30770,"derivative":{"exercise_price":6.2,"expiration_date":"2028-08-15","underlying":"Common Stock","underlying_shares":30770},"source":{"system":"sec-edgar","filing":"0001235802-18-000122","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580218000122/primary_doc.xml","form_type":"4"}},{"id":3841966,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Commercial Officer"}}],"security":"Common Stock, $0.000001 par value","published_at":"2018-08-16T16:54:49.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares will vest and be issued on July 9, 2021 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares will vest and be issued on July 9, 2021 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001235802-18-000122","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692661/000123580218000122/primary_doc.xml","form_type":"4"}},{"id":4020878,"issuer":{"id":159205,"kind":"organization","name":"RTI SURGICAL, INC.","symbol":"RTIX"},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP CCO-Domestic Direct"}}],"security":"Option to purchase common stock $.001 par value","published_at":"2018-03-02T10:26:13.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":43600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option will become exercisable as to 8,720 shares on each of 2/28/2019, 2/28/2020, 2/28/2021, 2/28/2022 and 2/28/2023."}],"balance_after":43600,"derivative":{"exercise_price":4.25,"expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":43600},"source":{"system":"sec-edgar","filing":"0001692661-18-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100441/000169266118000001/primary_doc.xml","form_type":"4"}},{"id":4020877,"issuer":{"id":159205,"kind":"organization","name":"RTI SURGICAL, INC.","symbol":"RTIX"},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP CCO-Domestic Direct"}}],"security":"Common Stock","published_at":"2018-03-02T10:26:13.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":19800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Award will become vested as to 6,600 on each of 2/28/2019, 2/28/2020 and 2/28/2021."}],"balance_after":146015,"source":{"system":"sec-edgar","filing":"0001692661-18-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100441/000169266118000001/primary_doc.xml","form_type":"4"}},{"id":4333565,"issuer":{"id":159205,"kind":"organization","name":"RTI SURGICAL, INC.","symbol":"RTIX"},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"EVP CCO-Domestic Direct"}}],"security":"Common Stock","published_at":"2017-05-04T15:32:42.000Z","date":"2017-05-03","kind":"purchase","acquired":true,"shares":33130,"price":4.52,"value":149747.6,"ownership":{"direct":true},"balance_after":126215,"source":{"system":"sec-edgar","filing":"0001692661-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100441/000169266117000002/primary_doc.xml","form_type":"4"}},{"id":4477442,"issuer":{"id":159205,"kind":"organization","name":"RTI SURGICAL, INC.","symbol":"RTIX"},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"EVP CCO-Domestic Direct"}}],"security":"Option to purchase common stock $.001 par value","published_at":"2017-01-30T12:00:27.000Z","date":"2017-01-24","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will become exercisable as to 12,500 shares on each of 1/24/2018, 1/24/2019, 1/24/2020, 1/24/2021 and 1/24/2022."}],"balance_after":62500,"derivative":{"exercise_price":3.15,"expiration_date":"2027-01-24","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001692661-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100441/000169266117000001/primary_doc.xml","form_type":"4"}},{"id":4477441,"issuer":{"id":159205,"kind":"organization","name":"RTI SURGICAL, INC.","symbol":"RTIX"},"owners":[{"id":88227,"kind":"person","name":"Brandt Kevin D","position":1,"cik":"0001692661","reported_name":"Brandt Kevin D","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"EVP CCO-Domestic Direct"}}],"security":"Common Stock","published_at":"2017-01-30T12:00:27.000Z","date":"2017-01-24","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Restricted Stock award will become vested as to 20,833 shares on both 1/24/2018 and 1/24/2019 and 20,834 shares on 1/24/2020."}],"balance_after":93085,"source":{"system":"sec-edgar","filing":"0001692661-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100441/000169266117000001/primary_doc.xml","form_type":"4"}}]}